1. Predictive Role for Serum Aldo-Keto Reductase Family1 Member B10 for Early Detection of Hepatocellular Carcinoma in Egyptian Patients
   Abdel-Naser Abdel-Atty Gadallah et al, 2022, Open Access Macedonian Journal of Medical Sciences CrossRef
2. New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
   Ting Wang et al, 2020, Frontiers in Oncology CrossRef
3. Role of Biomarkers in Hepatocellular Carcinoma and Their Disease Progression
   S.S. Haque et al, 2023, Liver Cancer - Genesis, Progression and Metastasis CrossRef
4. A novel diagnostic four-gene signature for hepatocellular carcinoma based on artificial neural network: Development, validation, and drug screening
   Min Chen et al, 2022, Frontiers in Genetics CrossRef
5. Serum Aldo-Keto Reductase Family 1 Member B10 (AKR1B10) as a Potential Biomarker for Diagnosis of Hepatocellular Carcinoma
   Ziran Wang et al, 2024, Journal of Hepatocellular Carcinoma CrossRef
6. Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
   Johanna DiStefano et al, 2019, Cancers CrossRef
7. Quantitative proteomics identifies a plasma multi-protein model for detection of hepatocellular carcinoma
   Zhenhua Du et al, 2020, Scientific Reports CrossRef